Leading science, pioneering therapies

Liver stem cells and regeneration group publications

2011

Forbes SJ, Parola M.  2011.  Liver fibrogenic cells.Best Pract Res Clin Gastroenterol. 25(2):207-17.
Hay DC, Pernagallo S, Diaz-Mochon JJose, Medine C.N, Greenhough S, Hannoun Z, Schrader J, Black JR, Fletcher J, Dalgetty D et al..  2011.  Unbiased screening of polymer libraries to define novel substrates for functional hepatocytes with inducible drug metabolism.Stem Cell Res. 6(2):92-102.
Gibbons MA, Mackinnon AC, Ramachandran P, Dhaliwal K, Duffin R, Phythian-Adams AT, van Rooijen N, Haslett C, Howie SE, A Simpson J et al..  2011.  Ly6Chi monocytes direct alternatively activated profibrotic macrophage regulation of lung fibrosis.Am J Respir Crit Care Med. 184(5):569-81.
Thomas JA, Pope C, Wojtacha D, Robson AJ, Gordon-Walker TT, Hartland SN, Ramachandran P, Van Deemter M, Hume DA, Iredale JP et al..  2011.  Macrophage therapy for murine liver fibrosis recruits host effector cells improving fibrosis, regeneration, and function.Hepatology. 53(6):2003-15.

2010

Kung JWC, Currie IS, Forbes SJ, Ross JA.  2010.  Liver development, regeneration, and carcinogenesis.J Biomed Biotechnol. 2010:984248.
Terrace JD, Hay DC, Samuel K, Anderson RA, Currie IS, Parks RW, Forbes SJ, Ross JA.  2010.  Portal venous endothelium in developing human liver contains haematopoietic and epithelial progenitor cells.Exp Cell Res. 316(9):1637-47.
Sullivan G, Hay DC, Park I-H, Fletcher J, Hannoun Z, Payne C, Dalgetty D, Black JR, Ross JA, Samuel K et al..  2010.  Generation of functional human hepatic endoderm from human induced pluripotent stem cells.Hepatology. 51(1):329-35.
Lorenzini S, Bird TG, Boulter L, Bellamy C, Samuel K, Aucott RL, Clayton E, Andreone P, Bernardi M, Golding M et al..  2010.  Characterisation of a stereotypical cellular and extracellular adult liver progenitor cell niche in rodents and diseased human liver.Gut. 59(5):645-54.
Stutchfield BM, Rashid S, Forbes SJ, Wigmore SJ.  2010.  Practical barriers to delivering autologous bone marrow stem cell therapy as an adjunct to liver resection.Stem Cells Dev. 19(2):155-62.
Stutchfield BM, Forbes SJ, Wigmore SJ.  2010.  Prospects for stem cell transplantation in the treatment of hepatic disease.Liver Transpl. 16(7):827-36.

2009

Kallis YN, Forbes SJ.  2009.  The bone marrow and liver fibrosis: friend or foe?Gastroenterology. 137(4):1218-21.
Kung JWC, Forbes SJ.  2009.  Stem cells and liver repair.Curr Opin Biotechnol. 20(5):568-74.
Terrace JD, Hay DC, Samuel K, Payne C, Anderson RA, Currie IS, Parks RW, Forbes SJ, Ross JA.  2009.  Side population cells in developing human liver are primarily haematopoietic progenitor cells.Exp Cell Res. 315(13):2141-53.
Thomas JA, Forbes SJ.  2009.  A fat chance for hepatocyte transplantation?Gut. 58(4):480-2.

2008

Hay DC, Fletcher J, Payne C, Terrace JD, Gallagher RCJ, Snoeys J, Black JR, Wojtacha D, Samuel K, Hannoun Z et al..  2008.  Highly efficient differentiation of hESCs to functional hepatic endoderm requires ActivinA and Wnt3a signaling.Proc Natl Acad Sci U S A. 105(34):12301-6.
Burra P, Tomat S, Villa E, Gasbarrini A, Costa AN, Conconi MT, Forbes SJ, Farinati F, Cozzi E, Alison MR et al..  2008.  Experimental hepatology applied to stem cells.Dig Liver Dis. 40(1):54-61.
Mackinnon AC, Farnworth SL, Hodkinson PS, Henderson NC, Atkinson KM, Leffler H, Nilsson UJ, Haslett C, Forbes SJ, Sethi T.  2008.  Regulation of alternative macrophage activation by galectin-3.J Immunol. 180(4):2650-8.
Henderson NC, Forbes SJ.  2008.  Hepatic fibrogenesis: from within and outwith.Toxicology. 254(3):130-5.
Lorenzini S, Isidori A, Catani L, Gramenzi A, Talarico S, Bonifazi F, Giudice V, Conte R, Baccarani M, Bernardi M et al..  2008.  Stem cell mobilization and collection in patients with liver cirrhosis.Aliment Pharmacol Ther. 27(10):932-9.

Pages